NMNs Fast Dissolve by Renue By Science — Ingredients, Evidence & Safety

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Beta-Nicotinamide Mononucleotide: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)

The product's safety score is low because the amount of Beta-Nicotinamide Mononucleotide included is over seven times the recommended upper limit.

Label Data

2 Tablet(s) Serving Size

120 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Beta-Nicotinamide Mononucleotide

250 mg

⚠️ Exceeds Tolerable Upper Intake Level by 7.1× (UL: 35 mg) 📚 193 studies (Tier A: 5, B: 63)

RDA 14mg This product: 250mg UL 35mg

Other Ingredients

Mannitol Crospovidone Natural Lemonade Flavor, Powder Monk Fruit Extract Magnesium Stearate Silica Microcrystalline Cellulose

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (90% of products) Nutrient (2% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Dairy Free

Product Information

📋 Directions for Use

Suggested Use For best results, take two (2) tablets daily.

⚠️ Warnings & Precautions

Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using.

Do not use if safety seal is broken or missing.

🧪 Formulation Notes

Supports: Cellular energy optimization Healthy aging Longevity

B - Nicotinamide Mononucleotide

No artificial colors, preservatives or additives. Non-GMO.

Suitable for vegans.

This product is manufactured in the United States at a FDA registered, NSF cGMP certified compliant facility.

Additional Information

Store tightly in a cool, dry place.

GMP Good Manufacturing Practice Certified

Product Details

UPC / SKU 6 56165 99713 8

DSLD Entry Date 2024-09-25

Product Type Non-Nutrient/Non-Botanical

Form Tablet or Pill

Brand Renue By Science

DSLD ID 319004

Data Updated 2026-04-11

Research Evidence

8 Research Sources

54 Avg Quality Score

4 Rct

2 Meta Analysis

2 Clinical Trial

B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials

Meta Analysis Critical reviews in food science and nutrition 2025

PubMed DOI

B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study

Rct GeroScience 2024

PubMed DOI

C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.

Rct Science (New York, N.Y.)

PubMed DOI

C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

Rct GeroScience

PubMed DOI

C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials

Meta Analysis Current diabetes reports 2024

PubMed DOI

C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial

Rct Scientific reports 2023

PubMed DOI

C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

Clinical Trial ClinicalTrials.gov 2021

ClinicalTrials.gov

C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function

Clinical Trial ClinicalTrials.gov 2017

ClinicalTrials.gov

View all evidence for Nmn →